ストックスクリーナーアプリを入手
93.46
2.45%
2.29
前日終値:
$91.17
開ける：
$91.44
24時間の取引高:
47,192
Relative Volume:
0.09
時価総額：
$6.48B
収益：
-
当期純損益:
$-173.59M
株価収益率:
-50.52
EPS:
-1.85
ネットキャッシュフロー:
$-130.44M
1週間 パフォーマンス:
+3.57%
1か月 パフォーマンス:
-7.68%
6か月 パフォーマンス:
+33.95%
1年 パフォーマンス:
+55.67%
1日の値動き範囲:
$90.11
$93.73
1週間の範囲:
$85.38
$93.14
52週間の値動き範囲:
$59.99
$113.51
Nuvalent Inc Stock (NUVL) Company Profile
NUVL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| NUVL | 93.42 | 6.48B | 0 | -173.59M | -130.44M | -1.85 |
| VRTX | 449.18 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.98 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 592.97 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.49 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.97 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-28 | 再開されました | Guggenheim | Buy |
| 2024-02-23 | 開始されました | Robert W. Baird | Outperform |
| 2023-09-27 | 開始されました | Stifel | Buy |
| 2023-08-08 | 開始されました | SVB Securities | Market Perform |
| 2023-07-24 | 開始されました | Guggenheim | Buy |
| 2023-01-18 | 開始されました | Wedbush | Outperform |
| 2022-06-24 | 開始されました | BMO Capital Markets | Outperform |
すべてを表示
Nuvalent Inc (NUVL) 最新ニュース
Nuvalent CEO Porter sells shares worth $2.37 million By Investing.com - Investing.com Australia
Nuvalent CEO Porter sells shares worth $2.37 million - Investing.com India
Nuvalent, Inc. (NASDAQ:NUVL) Position Reduced by Victory Capital Management Inc. - MarketBeat
First Turn Management LLC Acquires 106,838 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely - Simply Wall St
FY2024 EPS Estimates for Nuvalent Reduced by Leerink Partnrs - MarketBeat
What is Wedbush's Forecast for Nuvalent FY2024 Earnings? - MarketBeat
Perceptive Advisors LLC Expands Stake in Nuvalent Inc - GuruFocus.com
Paradigm Biocapital Advisors LP Acquires Significant Stake in Nu - GuruFocus.com
State of New Jersey Common Pension Fund D Makes New $2.41 Million Investment in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
How to Take Advantage of moves in (NUVL) - Stock Traders Daily
Nuvalent (NASDAQ:NUVL) Announces Quarterly Earnings Results - MarketBeat
Nuvalent (NASDAQ:NUVL) Stock Price Expected to Rise, BMO Capital Markets Analyst Says - MarketBeat
Nuvalent Reports Q3 2024 Progress and Financials - TipRanks
Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results - The Malaysian Reserve
Nuvalent Secures $1.2B Cash Runway Through 2028, Reports Strong Trial Progress | NUVL Stock News - StockTitan
Nuvalent Inc. (NUVL) Quarterly 10-Q Report - Quartzy
Crescent Biopharma Appoints Susan Moran, MD, MSCE, and Alexandra Balcom, MBA, CPA, to Board of Directors - The Malaysian Reserve
Nuvalent Appoints Chief Scientific Officer - Contract Pharma
AlphaCentric Advisors LLC Invests $716,000 in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent CFO Alexandra Balcom sells $891,879 in stock By Investing.com - Investing.com Canada
Nuvalent CFO Alexandra Balcom sells $891,879 in stock - Investing.com
Nuvalent's chief development officer Noci Darlene sells $442,980 in shares - Investing.com
Nuvalent's chief development officer Noci Darlene sells $442,980 in shares By Investing.com - Investing.com Australia
Nuvalent, Inc. (NASDAQ:NUVL) CFO Alexandra Balcom Sells 10,000 Shares - MarketBeat
abrdn plc Sells 40,233 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
(NUVL) Technical Data - Stock Traders Daily
Nuvalent, Inc. (NASDAQ:NUVL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Nuvalent to Present Updated Data for ROS1-Selective Inhibitor, Z - GuruFocus.com
Oversold Conditions For Nuvalent (NUVL) - Nasdaq
Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Sci - GuruFocus.com
PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update - StockTitan
Nuvalent to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GuruFocus.com
UBS Initiates Coverage of Nuvalent (NUVL) with Neutral Recommendation - MSN
Nuvalent, Inc. (NASDAQ:NUVL) Director Sells $195,500,000.00 in Stock - MarketBeat
Nuvalent sees $195.5 million stock sale by Deerfield Management - Investing.com
Nuvalent (NASDAQ:NUVL) Earns Neutral Rating from Analysts at UBS Group - MarketBeat
Where are the Opportunities in (NUVL) - Stock Traders Daily
Nuvalent (NASDAQ:NUVL) Shares Gap DownShould You Sell? - MarketBeat
Nuvalent CEO Porter sells shares worth $2.76 million - Investing.com
Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) CEO Sells 27,000 Shares of Stock - MarketBeat
Nuvalent CEO Porter sells shares worth $2.76 million By Investing.com - Investing.com UK
AQR Capital Management LLC Has $1.01 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
AQR Capital Management LLC Sells 8,783 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
The Attractiveness of Investing In Nuvalent Inc (NUVL) is Growing - Knox Daily
Financial Metrics Unveiled: Nuvalent Inc (NUVL)’s Key Ratios in the Spotlight - The Dwinnex
Nuvalent, Inc. (NASDAQ:NUVL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
NVL-655 overcomes ALK inhibitor limitations - BioWorld Online
JPMorgan Chase & Co. Boosts Nuvalent (NASDAQ:NUVL) Price Target to $125.00 - MarketBeat
Nuvalent executive sells over $500k in stock, buys $94.6k By Investing.com - Investing.com Australia
Nuvalent, Inc. (NASDAQ:NUVL) Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
Nuvalent Inc (NUVL) 財務データ
収益
当期純利益
現金流量
EPS
Nuvalent Inc (NUVL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Porter James Richard | President and CEO |
Nov 15 '24 |
Sale |
87.94 |
27,000 |
2,374,479 |
188,113 |
| Noci Darlene | Chief Development Officer |
Nov 01 '24 |
Option Exercise |
14.40 |
5,000 |
72,000 |
38,300 |
| Noci Darlene | Chief Development Officer |
Nov 01 '24 |
Sale |
88.60 |
5,000 |
442,980 |
33,300 |
| Balcom Alexandra | Chief Financial Officer |
Oct 31 '24 |
Option Exercise |
27.85 |
10,000 |
278,500 |
43,300 |
| Balcom Alexandra | Chief Financial Officer |
Oct 31 '24 |
Sale |
89.19 |
10,000 |
891,879 |
33,300 |
| Shair Matthew | Director |
Oct 28 '24 |
Sale |
91.73 |
2,000 |
183,468 |
224,522 |
| Flynn James E | Director |
Oct 22 '24 |
Sale |
97.75 |
2,000,000 |
195,500,000 |
8,670,512 |
0.42%
0.16%
大文字化:
|
ボリューム (24 時間):